17/18 January 2007 Wiener Neustadt - Czelo
17/18 January 2007 Wiener Neustadt - Czelo
17/18 January 2007 Wiener Neustadt - Czelo
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
ThalesNano Inc.<br />
Address Zahony utca 7 Hungary<br />
0 - Budapest<br />
Phone / Fax 0036-8808-500 / 0036-8808-501<br />
www www.thalesnano.com<br />
Size 11-50<br />
Organisation Type Company<br />
Contact Person<br />
Name Dr. Ferenc Darvas<br />
Position President<br />
Email ruud.dekater@thalesnano.com<br />
Type of co-operation (Offered, Requested) Areas of activity<br />
Licence agreement<br />
Technical Co-operation (R&D) Requested<br />
Joint research project Requested<br />
Joint-venture agreement<br />
Manufacturing agreement<br />
Commercial agreement Requested<br />
Financial agreement<br />
• Electronics, Microelectronics<br />
• Chemical Technology<br />
• Mechanical Engineering<br />
• Laboratory Equipment<br />
•<br />
Short description of company<br />
ThalesNano is a pioneer in the development of miniaturized continuous-flow hydrogenation reactors. Utilizing<br />
water electrolyses, for the in-situ production of hydrogen, a tailor made cartridge system ( CatCart TM ) and a<br />
continuous-flow mechanism, the H-Cube makes hydrogenation safe, easy and very efficient.<br />
A continuous flow of substrate is combined with hydrogen , the mixture can then be heated up to 100 degrees C,<br />
and pressurized up to 100 bar. It passes through a packed catalyst cartridge and within minutes product emerges<br />
for fast reduction and optimization.<br />
1. Profile: RTD: Cooperation on Catalyst Research and instrument application<br />
DESCRIPTION:The H-Cube has been accepted by the pharmaceutical and biotechnology industry as an<br />
important innovation in drug discovery- and research. ThalesNano continues to dedicate considerable resources<br />
to catalyst research and further instrument applications. In these fields the company cooperates with academia<br />
and third parties, and welcomes further extension of its research.<br />
INNOVATIVE ASPECTS:Miniaturization of continuous flow reactors, user-friendly software and operating mode.<br />
MAIN ADVANTADGES / BENEFITS:fast reactions in a safe and controlled environment.<br />
TECHNICAL SPECIFICATIONS:upon request<br />
CURRENT STAGE OF DEVELOPMEN Development has entered commercial phase two years ago.<br />
INTELLECTUAL PROPERTY RIGHTS (IPR):fully owned by ThalesNano Inc.<br />
MARKET APPLICATIONS:Drug discovery and research, Biochemistry, Green Chemistry, Catalytic research<br />
TYPE OF COLLABORATION SOUGHcatalytic research and instrument applications<br />
PARTNER PROFILE:<br />
2. Profile: RTD: Cooperation on Catalyst Research and instrument application<br />
3. Profile: RTD: Cooperation on Catalyst Research and instrument application
Change language